LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 139 filers reported holding LEGEND BIOTECH CORP in Q4 2021. The put-call ratio across all filers is 1.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $47,116,000 | -35.5% | 856,658 | -57.4% | 0.27% | -36.3% |
| Q1 2022 | $73,007,000 | -37.1% | 2,008,999 | -19.3% | 0.42% | -25.7% |
| Q4 2021 | $116,012,000 | -2.9% | 2,489,003 | +5.3% | 0.56% | +7.4% |
| Q3 2021 | $119,524,000 | +74.9% | 2,364,003 | +42.0% | 0.52% | +75.0% |
| Q2 2021 | $68,329,000 | +1936.6% | 1,664,534 | +1339.6% | 0.30% | +1900.0% |
| Q1 2021 | $3,355,000 | +3.0% | 115,626 | 0.0% | 0.02% | +25.0% |
| Q4 2020 | $3,256,000 | -17.7% | 115,626 | -9.8% | 0.01% | -25.0% |
| Q3 2020 | $3,958,000 | -31.1% | 128,200 | -5.0% | 0.02% | -36.0% |
| Q2 2020 | $5,746,000 | – | 135,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |